These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15307581)

  • 1. Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test.
    Ravn P; Munk ME; Andersen AB; Lundgren B; Nielsen LN; Lillebaek T; Soerensen IJ; Andersen P; Weldingh K
    Scand J Infect Dis; 2004; 36(6-7):499-501. PubMed ID: 15307581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10].
    Harada N; Higuchi K; Sekiya Y; Rothel J; Kitoh T; Mori T
    Kekkaku; 2004 Dec; 79(12):725-35. PubMed ID: 15782618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.
    Ravn P; Munk ME; Andersen AB; Lundgren B; Lundgren JD; Nielsen LN; Kok-Jensen A; Andersen P; Weldingh K
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):491-6. PubMed ID: 15817755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10.
    Brock I; Munk ME; Kok-Jensen A; Andersen P
    Int J Tuberc Lung Dis; 2001 May; 5(5):462-7. PubMed ID: 11336278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
    Kawabe Y
    Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved diagnosis of tuberculosis in HIV-positive patients using RD1-encoded antigen CFP-10.
    Rao PV; Murthy MK; Basirudeen S; Sharma P; Swaminathan S; Raja A
    Int J Infect Dis; 2009 Sep; 13(5):613-22. PubMed ID: 19119038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection.
    Arend SM; Franken WP; Aggerbeck H; Prins C; van Dissel JT; Thierry-Carstensen B; Tingskov PN; Weldingh K; Andersen P
    Tuberculosis (Edinb); 2008 May; 88(3):249-61. PubMed ID: 18155963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study.
    Goletti D; Carrara S; Vincenti D; Saltini C; Rizzi EB; Schininà V; Ippolito G; Amicosante M; Girardi E
    Clin Microbiol Infect; 2006 Jun; 12(6):544-50. PubMed ID: 16700703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10.
    Arend SM; Ottenhoff TH; Andersen P; van Dissel JT
    Int J Tuberc Lung Dis; 2001 Jul; 5(7):680-6. PubMed ID: 11467375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for tuberculosis among children.
    Nakaoka H; Lawson L; Squire SB; Coulter B; Ravn P; Brock I; Hart CA; Cuevas LE
    Emerg Infect Dis; 2006 Sep; 12(9):1383-8. PubMed ID: 17073087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
    Matulis G; Jüni P; Villiger PM; Gadola SD
    Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis.
    Inui N; Suda T; Chida K
    Respir Med; 2008 Feb; 102(2):313-5. PubMed ID: 17980570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy.
    Latorre I; Altet N; de Souza-Galvão M; Ruiz-Manzano J; Lacoma A; Prat C; Pérez M; Ausina V; Domínguez J
    Scand J Infect Dis; 2012 Mar; 44(3):161-7. PubMed ID: 21923628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
    Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
    Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.